Profound Medical (TSE:PRN) Hits New 12-Month High – What’s Next?

Profound Medical Corp. (TSE:PRN)’s stock price hit a new 52-week high during trading on Tuesday . The stock traded as high as C$12.40 and last traded at C$11.85, with a volume of 11025 shares changing hands. The stock had previously closed at C$12.11.

Profound Medical Price Performance

The stock has a market capitalization of C$421.00 million, a PE ratio of -8.79 and a beta of 1.19. The business’s 50-day moving average price is C$9.67 and its 200 day moving average price is C$8.15. The company has a debt-to-equity ratio of 20.05, a quick ratio of 14.98 and a current ratio of 6.12.

Profound Medical (TSE:PRN) last posted its quarterly earnings data on Thursday, November 13th. The company reported C$0.26 earnings per share (EPS) for the quarter. Profound Medical had a negative return on equity of 85.22% and a negative net margin of 349.41%.The company had revenue of C$7.36 million during the quarter. Research analysts forecast that Profound Medical Corp. will post -1.9000001 earnings per share for the current year.

About Profound Medical

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.